Thiophene ring-opening reactions. Part VII: synthesis and antitumor, anti-inflammatory, and antioxidant properties of 1,3,4‒thiadiazoline‒6-sulfanylthiopyran-4(1H)-one hybrids
Shaima K. Alsawaleha, Jalal A. Zahra, Mustafa M. El-Abadelah, Violet Kasabri, Salim S. Sabri, Monther A. Khanfar
{"title":"Thiophene ring-opening reactions. Part VII: synthesis and antitumor, anti-inflammatory, and antioxidant properties of 1,3,4‒thiadiazoline‒6-sulfanylthiopyran-4(1H)-one hybrids","authors":"Shaima K. Alsawaleha, Jalal A. Zahra, Mustafa M. El-Abadelah, Violet Kasabri, Salim S. Sabri, Monther A. Khanfar","doi":"10.1007/s00044-024-03343-8","DOIUrl":null,"url":null,"abstract":"<div><p>The reaction of <i>N</i>′’(aryl)benzothiohydrazides with 2-chloro-6-((substituted)amino)-3-nitro-4-oxo-4H-thieno[2,3-b]thiopyran-5-carboxylate (<b>13</b>-<b>15</b>) under basic conditions (NEt<sub>3</sub>) in acetonitrile proceeds via thiophene ring-opening processes and yields, upon addition of iodomethane, the respective 1,3,4-thiadiazoline-6-sulfanylthiopyran-4(1<i>H</i>)-one hybrids. The new compounds were characterized by HRMS and NMR spectral data and confirmed by single-crystal X-ray crystallography. The cytotoxicity affinities for compounds <b>10</b>-<b>17</b> were evaluated in cross-correlations with their anti-inflammation and radical scavenging capacities. Compound <b>13</b> exhibited the highest cytotoxic properties, with IC<sub>50</sub> values ranging from 160 nM in mammary T47D to less than 20.35 µM in colorectal CACO2 among 12 diverse cancer monolayers. Compound <b>17c</b> significantly reduced lung and mammary cancer cell viability, with anti-tumorigenesis IC<sub>50</sub> values of less than 10 µM. These new compounds have the potential to be further optimized into novel selective cytotoxic treatments.</p><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"34 2","pages":"392 - 405"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-024-03343-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The reaction of N′’(aryl)benzothiohydrazides with 2-chloro-6-((substituted)amino)-3-nitro-4-oxo-4H-thieno[2,3-b]thiopyran-5-carboxylate (13-15) under basic conditions (NEt3) in acetonitrile proceeds via thiophene ring-opening processes and yields, upon addition of iodomethane, the respective 1,3,4-thiadiazoline-6-sulfanylthiopyran-4(1H)-one hybrids. The new compounds were characterized by HRMS and NMR spectral data and confirmed by single-crystal X-ray crystallography. The cytotoxicity affinities for compounds 10-17 were evaluated in cross-correlations with their anti-inflammation and radical scavenging capacities. Compound 13 exhibited the highest cytotoxic properties, with IC50 values ranging from 160 nM in mammary T47D to less than 20.35 µM in colorectal CACO2 among 12 diverse cancer monolayers. Compound 17c significantly reduced lung and mammary cancer cell viability, with anti-tumorigenesis IC50 values of less than 10 µM. These new compounds have the potential to be further optimized into novel selective cytotoxic treatments.
N ' '(芳基)苯并噻唑肼与2-氯-6-(取代)氨基)-3-硝基-4-氧-4- h -噻吩[2,3-b]硫代吡喃-5-羧酸盐(13-15)在乙腈碱性条件下通过噻吩开环过程进行反应,在加入碘甲烷后,分别得到1,3,4-噻二唑-6-磺胺基硫代吡喃-4(1H)- 1杂化物。用HRMS和NMR谱数据对新化合物进行了表征,并用单晶x射线晶体学对其进行了确证。化合物10-17的细胞毒性亲和性与抗炎能力和自由基清除能力相互关联。化合物13表现出最高的细胞毒性,在12种不同的肿瘤单层中,其IC50值从乳腺T47D的160 nM到结直肠CACO2的20.35µM以下。化合物17c显著降低肺癌和乳腺癌细胞活力,抗肿瘤IC50值小于10µM。这些新化合物有可能进一步优化为新的选择性细胞毒治疗方法。
期刊介绍:
Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.